Catalyst Pharmaceuticals, Inc.
CPRXNASDAQHealthcareBiotechnology
As of Jul 21, 2026 close
- Market cap
- $4.00B
- P/E (TTM)
- 18.06
- Forward P/E
- 16.14
- Dividend yield
- -
- 52-week range
- $20.26$32.56
- Volume (live)
- -
- Avg. volume (3M)
- -
Catalyst Pharmaceuticals (CPRX) Stock Price & Financial Analysis
Catalyst Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $31.49 - $31.49 |
|---|---|
| 52-Week High | $32.56 |
| 52-Week Low | $20.26 |
| Open | $31.49 |
| Revenue (TTM) | 596.96M |
|---|---|
| Net Income (TTM) | 221.32M |
| Free Cash Flow (TTM) | 208.13M |
| EPS (TTM) | $1.74 |
| Profit Margin | 37.08% |
| Operating Margin | 44.83% |
| Return on Equity (ROE) | 21.85% |
| Debt to Equity | 0.00 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 4.00B |
|---|---|
| Shares Outstanding | 126.90M |
| P/E Ratio (TTM) | 18.06 |
| Forward P/E | 16.14 |
| Price to Sales (P/S) | 6.69 |
| Price to Book (P/B) | 3.95 |
| EV/EBITDA | 10.23 |
| 50-Day MA | $31.35 |
|---|---|
| 200-Day MA | $25.64 |
| 1-Year Change | +53.39% |
Source: Market prices and company fundamentals. Data as of Jul 21, 2026. Data sources and methodology
Catalyst Pharmaceuticals at a Glance
As of the Jul 21, 2026 close, Catalyst Pharmaceuticals (CPRX) has a market capitalization of $4.00B. The stock trades at 18.1× trailing earnings, 16.1× forward earnings and 6.7× sales. Over the trailing twelve months it earned $221.32M on revenue of $596.96M (a 37.1% profit margin) and generated $208.13M of free cash flow. Revenue grew 11.7% year over year.
As of its latest reported balance sheet, it holds $755.86M in cash and securities against $2.68M of debt, a net cash position of $753.18M.
Catalyst Pharmaceuticals does not currently pay a dividend.
The share price is up 53.4% over the past year. At $31.49 (the Jul 21, 2026 close) it sits near the top of its 52-week range of $20.26 to $32.56, above its 200-day moving average of $25.64.
Frequently Asked Questions About Catalyst Pharmaceuticals
What is the current stock price for CPRX?
As of the Jul 21, 2026 close, CPRX stock trades at $31.49. The 52-week range is $20.26–$32.56, with a day range of $31.49–$31.49.
What is the P/E ratio for CPRX?
As of the Jul 21, 2026 close, Catalyst Pharmaceuticals's trailing twelve-month (TTM) P/E ratio is 18.1, meaning investors pay $18.1 for every $1 of annual earnings. The forward P/E is 16.1, reflecting analyst expectations for future earnings. Catalyst Pharmaceuticals operates in the Healthcare sector.
Does CPRX pay dividends?
Catalyst Pharmaceuticals does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for CPRX?
Analyst ratings and recommendations for CPRX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of CPRX?
As of the Jul 21, 2026 close, Catalyst Pharmaceuticals's market capitalization is $4.00B, classifying it as a mid-cap company. Catalyst Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.